How CDC Is Making COVID-19 Vaccine Recommendations

How CDC Is Making COVID-19 Vaccine Recommendations

When the Food and Drug Administration (FDA) authorizes or approves a COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) will quickly hold a public meeting to review all available data about that vaccine (sign up to receive email updates whenever ACIP’s Meeting Information is updated). Before making recommendations, ACIP reviews all available clinical trial information, including descriptions of:

  • Who is receiving each vaccine (age, race, ethnicity, underlying medical conditions)
  • How different groups respond to the vaccine
  • Side effects of each vaccine

From these data, ACIP will then vote on whether to recommend the vaccine. ACIP also votes on recommendations for who should be offered COVID-19 vaccine first when supplies are limited.

COVID-19 Vaccination Recommendations

Learn more about ACIP and CDC recommendations for COVID-19 Vaccines.

Ethical principles

ACIP identified four ethical principles to guide their decision-making process when supply is limited:

  • Maximize benefits and minimize harms — Respect and care for people using the best available data to promote public health and minimize death and severe illness.
  • Mitigate health inequities — Reduce health disparities in the burden of COVID-19 disease and death, and make sure everyone has the opportunity to be as healthy as possible.
  • Promote justice — Treat affected groups, populations, and communities fairly. Remove unfair, unjust, and avoidable barriers to COVID-19 vaccination.
  • Promote transparency — Make a decision that is clear, understandable, and open for review. Allow and seek public participation in the creation and review of the decision processes.

​​Learn more about ACIP’s Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine.​

Other frameworks

Input from the public and the following professional groups is informing ACIP’s discussions on who should receive COVID-19 vaccines when supply is limited: